Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

Last year, Keytruda generated ... approved a $30.2 million grant to Merck, contingent on the company’s decision to set up operations at the Chestnut Run Innovation & Science Park (CRISP ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Keytruda is set to lose exclusivity in 2028, meaning Summit may face competition from cheaper biosimilars. Meanwhile, other ...

A groundbreaking ceremony was held at Chestnut Run Innovation & Science Park on April 29, bringing together business and government officials to celebrate the milestone. Merck’s facility ...

Merck starts construction on a $1B biologics facility in Wilmington, Del., expected to create 500+ jobs and support Keytruda production.

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

Merck breaks ground on new $1 billion biologics center of excellence in Wilmington, Delaware: Rahway, New Jersey Wednesday, April 30, 2025, 09:00 Hrs [IST] Merck, known as MSD out ...

Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

Located at Chestnut Run Innovation & Science Park, the Merck Wilmington Biotech project will comprise laboratory, ...

A groundbreaking ceremony was held at Chestnut Run Innovation & Science Park on April 29, bringing together business and government officials to celebrate the milestone. Merck’s facility ...